Advanced glycation end products reduce macrophage-mediated killing of Staphylococcus aureus by ARL8 upregulation and inhibition of autolysosome formation.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
08 2020
Historique:
received: 19 11 2019
revised: 25 02 2020
accepted: 31 03 2020
pubmed: 7 4 2020
medline: 16 12 2020
entrez: 7 4 2020
Statut: ppublish

Résumé

Staphylococcus aureus, a pathogen most frequently found in diabetic foot ulcer infection, was recently suggested as an intracellular pathogen. Autophagy in professional phagocytes like macrophages allows selective destruction of intracellular pathogens, and its dysfunction can increase the survival of internalized pathogens, causing infections to worsen and spread. Previous works have shown that S. aureus infections in diabetes appeared more severe and invasive, and coincided with the suppressed autophagy in dermal tissues of diabetic rat, but the exact mechanisms are unclear. Here, we demonstrated that accumulation of advanced glycation end products (AGEs) contributed to the diminished autophagy-mediated clearance of S. aureus in the macrophages differentiated from PMA-treated human monocytic cell line THP-1. Importantly, infected macrophages showed increased S. aureus containing autophagosome, but the subsequent fusion of S. aureus containing autophagosome and lysosome was suppressed in AGEs-pretreated cells, suggesting AGEs blocked the autophagic flux and enabled S. aureus survival and escape. At the molecular level, elevated lysosomal ARL8 expression in AGEs-treated macrophages was required for AGEs-mediated inhibition of autophagosome-lysosome fusion. Silencing ARL8 in AGEs-treated macrophages restored autophagic flux and increased S. aureus clearance. Our results therefore demonstrate a new mechanism, in which AGEs accelerate S. aureus immune evasion in macrophages by ARL8-dependent suppression of autophagosome-lysosome fusion and bactericidal capability.

Identifiants

pubmed: 32250445
doi: 10.1002/eji.201948477
doi:

Substances chimiques

Glycation End Products, Advanced 0
ARL5B protein, human EC 3.6.1.2
ADP-Ribosylation Factors EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1174-1186

Subventions

Organisme : National Key R&D Program of China
ID : 2016YFC0901200
Pays : International
Organisme : National Natural Science Foundation of China
ID : 81770827
Pays : International
Organisme : National Natural Science Foundation of China
ID : 81972967
Pays : International
Organisme : Guangdong Science and Technology Department
ID : 2017B030314026
Pays : International
Organisme : Guangdong Medical Research Fund Project
ID : A2018365
Pays : International
Organisme : Guangdong Basic and Applied Basic Research Foundation
ID : 2017A020215017
Pays : International
Organisme : Guangdong Basic and Applied Basic Research Foundation
ID : 2019A1515011754
Pays : International

Informations de copyright

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Lipsky, B. A., Aragon-Sanchez, J., Diggle, M., Embil, J., Kono, S., Lavery, L., Senneville, E. et al., IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab. Res. Rev. 2016. 32(Suppl 1): 45-74.
Sangeorzan, B J., Residual infection after forefoot amputation in diabetic foot infection: is new information helpful even when negative? J. Bone. Joint Surg. Am. 2018. 100: 1447.
Wukich, D. K., Hobizal, K. B. and Brooks, M. M., Severity of diabetic foot infection and rate of limb salvage. Foot Ankle Int. 2013. 34: 351-358.
Troisi, N., Ercolini, L., Chisci, E., Baggiore, C., Chechi, T., Manetti, F., Del Pin, B. et al., Diabetic foot infection: preliminary results of a fast-track program with early endovascular revascularization and local surgical treatment. Ann. Vasc. Surg. 2016. 30: 286-291.
Jiang, Y., Ran, X., Jia, L., Yang, C., Wang, P., Ma, J., Chen, B. et al., Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China. Int. J. Low Extrem. Wounds 2015. 14: 19-27.
Xie, X., Bao, Y., Ni, L., Dan, L., Niu, S., Lin, H., Li, H. et al., Bacterial profile and antibiotic resistance in patients with diabetic foot ulcer in Guangzhou, Southern China: focus on the differences among different Wagner's grades, IDSA/IWGDF grades, and ulcer types. Int. J. Endocrinol. 2017. 2017: 8694903.
Fraunholz, M. and Sinha, B., Intracellular Staphylococcus aureus: live-in and let die. Front. Cell. Infect. Microbiol. 2012. 2: 43.
López de Armentia, M. M., Gauron, M. C. and Colombo, M. I., Staphylococcus aureus alpha-toxin induces the formation of dynamic tubules labeled with LC3 within host cells in a Rab7 and Rab1b-dependent manner. Front. Cell. Infect. Microbiol. 2017. 7: 431.
Liu, P. F., Cheng, J. S., Sy, C. L., Huang, W. C., Yang, H. C., Gallo, R. L., Huang, C. M. et al., IsaB inhibits autophagic flux to promote host transmission of methicillin-resistant Staphylococcus aureus. J. Invest. Dermatol. 2015. 135: 2714-2722.
Brancato, S. K. and Albina, J E., Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 2011. 178: 19-25.
Weiss, G. and Schaible, U. E., Macrophage defense mechanisms against intracellular bacteria. Immunol. Rev. 2015. 264: 182-203.
Khan, A. and Jagannath, C., Analysis of host-pathogen modulators of autophagy during Mycobacterium tuberculosis infection and therapeutic repercussions. Int. Rev. Immunol. 2017. 36: 271-286.
Palmer, G. E., Autophagy in the invading pathogen. Autophagy 2007. 3: 251-253.
Dagdas, Y. F., Pandey, P., Tumtas, Y., Sanguankiattichai, N., Belhaj, K., Duggan, C., Leary, A. Y. et al., Host autophagy machinery is diverted to the pathogen interface to mediate focal defense responses against the Irish potato famine pathogen. Elife 2018. 7. https://doi.org/10.7554/eLife.37476
Bah, A. and Vergne, I., Macrophage autophagy and bacterial infections. Front. Immunol. 2017. 8: 1483.
Vlassara, H. and Uribarri, J., Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr. Diab. Rep. 2014. 14: 453.
Stensen, M. H., Tanbo, T., Storeng, R. and Fedorcsak, P., Advanced glycation end products and their receptor contribute to ovarian ageing. Hum. Reprod. 2014. 29: 125-134.
Wautier, M. P., Tessier, F. J. and Wautier, J. L., Advanced glycation end products: a risk factor for human health. Ann. Pharm. Fr. 2014. 72: 400-408.
Mitsuhashi, T., Nakayama, H., Itoh, T., Kuwajima, S., Aoki, S., Atsumi, T. and Koike, T., Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 1993. 42: 826-832.
Singh, R., Barden, A., Mori, T. and Beilin, L., Advanced glycation end-products: a review. Diabetologia, 2001. 44: 129-146.
Guo, Y., Lin, C., Xu, P., Wu, S., Fu, X., Xia, W. and Yao, M., AGEs induced autophagy impairs cutaneous wound healing via stimulating macrophage polarization to M1 in diabetes. Sci. Rep. 2016. 6: 36416.
Sun, K., Wang, W., Wang, C., Lao, G., Liu, D., Mai, L., Yan, L. et al., AGEs trigger autophagy in diabetic skin tissues and fibroblasts. Biochem. Biophys. Res. Commun. 2016. 471: 355-360.
Zhao, X., Chen, Y., Tan, X., Zhang, L., Zhang, H., Li, Z., Liu, S. et al., Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB. J. Pathol. 2018. 245: 235-248.
Eskelinen, E L., Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med. 2006. 27: 495-502.
Khatter, D., Raina, V. B., Dwivedi, D., Sindhwani, A., Bahl, S. and Sharma, M., The small GTPase Arl8b regulates assembly of the mammalian HOPS complex on lysosomes. J. Cell Sci. 2015. 128: 1746-1761.
Hurlow, J. J., Humphreys, G. J., Bowling, F. L. and McBain, A. J., Diabetic foot infection: a critical complication. Int Wound. J 2018. 15: 814-821.
Chen, Y. E., Fischbach, M. A. and Belkaid, Y., Skin microbiota-host interactions. Nature 2018. 553: 427-436.
Dupasquier, M., Stoitzner, P., van Oudenaren, A., Romani, N. and Leenen, P. J., Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J. Invest. Dermatol. 2004. 123: 876-879.
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luevano-Contreras, C., Macias-Cervantes, M. H. et al., Dietary advanced glycation end products and their role in health and disease. Adv. Nutr. 2015. 6: 461-473.
Klessens, C. Q. F., Zandbergen, M., Wolterbeek, R., Bruijn, J. A., Rabelink, T. J., Bajema, I. M. and DHT, I. J., Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrol. Dial. Transplant. 2017. 32: 1322-1329.
Randow, F. and Munz, C., Autophagy in the regulation of pathogen replication and adaptive immunity. Trends Immunol. 2012. 33: 475-487.
Huang, J. and Brumell, J. H., Bacteria-autophagy interplay: a battle for survival. Nat. Rev. Microbiol. 2014. 12: 101-114.
McEwan, D G., Host-pathogen interactions and subversion of autophagy. Essays Biochem. 2017. 61: 687-697.
Lopez de Armentia, M. M., Gauron, M. C. and Colombo, M. I., Staphylococcus aureus alpha-toxin induces the formation of dynamic tubules labeled with LC3 within host cells in a Rab7 and Rab1b-dependent manner. Front Cell Infect Microbiol 2017. 7: 431.
Mrakovic, A., Kay, J. G., Furuya, W., Brumell, J. H. and Botelho, R. J., Rab7 and Arl8 GTPases are necessary for lysosome tubulation in macrophages. Traffic 2012. 13: 1667-1679.
Korolchuk, V. I. and Rubinsztein, D C., Regulation of autophagy by lysosomal positioning. Autophagy 2011. 7: 927-928.
Wei, Y., Zou, Z., Becker, N., Anderson, M., Sumpter, R., Xiao, G., Kinch, L. et al., EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 2013. 154: 1269-1284.
Korolchuk, V. I., Saiki, S., Lichtenberg, M., Siddiqi, F. H., Roberts, E. A., Imarisio, S., Jahreiss, L. et al., Lysosomal positioning coordinates cellular nutrient responses. Nat. Cell Biol. 2011. 13: 453-460.
Willett, R., Martina, J. A., Zewe, J. P., Wills, R., Hammond, G. R. V. and Puertollano, R., TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes. Nat. Commun. 2017. 8: 1580.

Auteurs

Xiaoying Xie (X)

Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Chuan Yang (C)

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Chaohui Duan (C)

Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Hongxing Chen (H)

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Tingting Zeng (T)

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Songyin Huang (S)

Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Hongyu Li (H)

Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Meng Ren (M)

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Wei-Jye Lin (WJ)

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Medical Research Center of Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Li Yan (L)

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH